Cargando…

Editorial: Portal Hypertension in Cirrhosis: From Pathogenesis to Novel Treatments

Detalles Bibliográficos
Autores principales:	Herath, Chandana B., Angus, Peter W., Trebicka, Jonel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978555/ https://www.ncbi.nlm.nih.gov/pubmed/35388286 http://dx.doi.org/10.3389/fphys.2022.864083

Ejemplares similares

Blockade of Mas Receptor or Mas-Related G-Protein Coupled Receptor Type D Reduces Portal Pressure in Cirrhotic but Not in Non-cirrhotic Portal Hypertensive Rats
por: Gunarathne, Lakmie S., et al.
Publicado: (2019)

Portal hypertension in cirrhosis: Pathophysiological mechanisms and therapy
por: Iwakiri, Yasuko, et al.
Publicado: (2021)

Managing portal hypertension in patients with liver cirrhosis
por: Sauerbruch, Tilman, et al.
Publicado: (2018)

Future therapy of portal hypertension in liver cirrhosis – a guess
por: Sauerbruch, Tilman, et al.
Publicado: (2014)

Mas‐related G protein‐coupled receptor type D antagonism improves portal hypertension in cirrhotic rats
por: Gunarathne, Lakmie S., et al.
Publicado: (2022)

Cirrhotic portal hypertension: From pathophysiology to novel therapeutics
por: Gunarathne, Lakmie S, et al.
Publicado: (2020)

Bile Acids, Liver Cirrhosis, and Extrahepatic Vascular Dysfunction
por: Sauerbruch, Tilman, et al.
Publicado: (2021)

Cyclic GMP in Liver Cirrhosis—Role in Pathophysiology of Portal Hypertension and Therapeutic Implications
por: Kreisel, Wolfgang, et al.
Publicado: (2021)

Portal vein thrombosis in patients with cirrhosis
por: von Köckritz, Leona, et al.
Publicado: (2017)

Extrahepatic Surgery in Cirrhosis Significantly Increases Portal Pressure in Preclinical Animal Models
por: Chang, Johannes, et al.
Publicado: (2021)

Update on New Aspects of the Renin-Angiotensin System in Hepatic Fibrosis and Portal Hypertension: Implications for Novel Therapeutic Options
por: Rajapaksha, Indu G., et al.
Publicado: (2021)

Hemodynamic Effects of the Non-Peptidic Angiotensin-(1-7) Agonist AVE0991 in Liver Cirrhosis
por: Klein, Sabine, et al.
Publicado: (2015)

Soluble TNF-Alpha-Receptors I Are Prognostic Markers in TIPS-Treated Patients with Cirrhosis and Portal Hypertension
por: Trebicka, Jonel, et al.
Publicado: (2013)

Activation of the Alternate Renin-Angiotensin System Correlates with the Clinical Status in Human Cirrhosis and Corrects Post Liver Transplantation
por: Casey, Stephen, et al.
Publicado: (2019)

Novel Rat Model of Repetitive Portal Venous Embolization Mimicking Human Non-Cirrhotic Idiopathic Portal Hypertension
por: Klein, Sabine, et al.
Publicado: (2016)

Von Willebrand and Factor VIII Portosystemic Circulation Gradient in Cirrhosis: Implications for Portal Vein Thrombosis
por: Praktiknjo, Michael, et al.
Publicado: (2020)

Phosphodiesterases in the Liver as Potential Therapeutic Targets of Cirrhotic Portal Hypertension
por: Kreisel, Wolfgang, et al.
Publicado: (2020)

Etiology and Complications of Portal Vein Thrombosis
por: Trebicka, Jonel, et al.
Publicado: (2014)

The rationale and study design of two phase II trials examining the effects of BI 685509, a soluble guanylyl cyclase activator, on clinically significant portal hypertension in patients with compensated cirrhosis
por: Reiberger, Thomas, et al.
Publicado: (2023)

The role of gut-liver axis in the pathogenesis of liver cirrhosis and portal hypertension
por: Seo, Yeon Seok, et al.
Publicado: (2012)

Role of portal venous platelet activation in patients with decompensated cirrhosis and TIPS
por: Queck, Alexander, et al.
Publicado: (2020)

Editorial: Hepatic immune response underlying liver cirrhosis and portal hypertension
por: Guo, Yangkun, et al.
Publicado: (2023)

Serum levels of bone sialoprotein correlate with portal pressure in patients with liver cirrhosis
por: Benz, Fabian, et al.
Publicado: (2020)

The kidney in cirrhosis with portal hypertension
por: Olteanu, D, et al.
Publicado: (2010)

Editorial: Alcohol-associated liver disease—From pathogenesis to treatment
por: Kharbanda, Kusum K., et al.
Publicado: (2022)

Editorial: Portal hypertension in cirrhosis and liver vascular diseases: from ethiopathogenesis to current strategies
por: Luo, Xuefeng, et al.
Publicado: (2023)

Hematological Indices in Portal Hypertension: Cirrhosis versus Noncirrhotic Portal Hypertension
por: Sahin, Abdurrahman, et al.
Publicado: (2018)

Editorial: Diabetes and Heart Failure: Pathogenesis and Novel Therapeutic Approaches
por: de Lucia, Claudio, et al.
Publicado: (2019)

Pathophysiological role of prostanoids in coagulation of the portal venous system in liver cirrhosis
por: Queck, Alexander, et al.
Publicado: (2019)

Beta-blockers in patients with liver cirrhosis: Pragmatism or perfection?
por: Sauerbruch, Tilman, et al.
Publicado: (2023)

Hemodynamic alterations in cirrhosis and portal hypertension
por: Kim, Moon Young, et al.
Publicado: (2010)

Advances and challenges in cirrhosis and portal hypertension
por: Berzigotti, Annalisa
Publicado: (2017)

Current therapies and novel approaches for biliary diseases
por: Rajapaksha, Indu G, et al.
Publicado: (2019)

Surveillance for portal hypertension in the course of liver cirrhosis
por: Piekarska, Anna, et al.
Publicado: (2018)

Extrapulmonary Sarcoidosis Manifested as Cirrhosis with Portal Hypertension
por: Kothakota, Sunil Raviraj, et al.
Publicado: (2021)

Role of circulating angiogenin levels in portal hypertension and TIPS
por: Queck, Alexander, et al.
Publicado: (2021)

Statins activate the canonical hedgehog-signaling and aggravate non-cirrhotic portal hypertension, but inhibit the non-canonical hedgehog signaling and cirrhotic portal hypertension
por: Uschner, Frank E., et al.
Publicado: (2015)

Editorial: Essential Pathways and Circuits of Autism Pathogenesis
por: Dölen, Gül, et al.
Publicado: (2016)

Transjugular intrahepatic portal shunt in the treatment of portal hypertension due to cirrhosis: single center experience
por: Chen, Yun, et al.
Publicado: (2019)

A Narrative Review on Non-Cirrohotic Portal Hypertension: Not All Portal Hypertensions Mean Cirrhosis
por: Fiordaliso, Michele, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_eond55dfn4ac2qcmvuepk60ndt